Naoko Nagatani
Kanazawa, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
RB1 controls differentiation through positive regulation of phosphoglycerate mutases.
Journal: Cell death & disease
Published: February 25, 2025
Treatment of Retinoblastoma 1-Intact Hepatocellular Carcinoma With Cyclin-Dependent Kinase 4/6 Inhibitor Combination Therapy.
Journal: Hepatology (Baltimore, Md.)
Published: November 03, 2020
Pharmacologically targetable vulnerability in prostate cancer carrying RB1-SUCLA2 deletion.
Journal: Oncogene
Published: January 24, 2020
Retinoblastoma Inactivation Induces a Protumoral Microenvironment via Enhanced CCL2 Secretion.
Journal: Cancer research
Published: November 19, 2018
Undifferentiated State Induced by Rb-p53 Double Inactivation in Mouse Thyroid Neuroendocrine Cells and Embryonic Fibroblasts.
Journal: Stem cells (Dayton, Ohio)
Published: October 21, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026